The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Author(s):
Passweg, J.R.; Baldomero, H.; Basak, G.W.; Chabannon, C.; Corbacioglu, S.; Duarte, R.; Kuball, J.; Lankester, A.; Montoto, S.; Latour, R.P. de; Snowden, J.A.; Styczynski, J.; Yakoub-Agha, I.; Arat, M.; Mohty, M.; Kroger, N.; European Soc Blood Marrow Transpla
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-10-31
Language
English
Is part of
Bone Marrow Transplantation (2019), Vol. 54, no. 10, p. 1575-1585
hdl
1887/120458
doi
10.1038/s41409-019-0465-9